RIGVIR® Mode of Action
RIGVIR® finds and infects tumour cells. This process is called oncotropism. Subsequently, RIGVIR® replicates in tumour cells and destroys them. This process is called oncolysis. Both processes, oncotropism and oncolysis, are selective for tumour cells and healthy cells are only minimally affected, if at all.
Please note that this animation is artist’s view of the real operating mechanism of oncolytic virotherapy.